序号 |
标题 |
次数 |
作者 |
发布时间 |
76366 |
cas:1245813-70-0,tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate |
77 |
kx |
2024-12-20 |
76367 |
鼠尾草酸脂质体,LP-CA,定制服务 |
123 |
axc |
2024-12-20 |
76368 |
Boc-L-Phe(4-CH2-N3)-OH,205127-59-9,Boc-L-苯丙氨酸(4-氨基甲基-叠氮)-羟基 |
87 |
wyh |
2024-12-20 |
76369 |
Fmoc-PEG4-Val-Cit-PAB-OH, CAS号:2055024-58-1 |
79 |
WYQ |
2024-12-20 |
76370 |
HOOCCH2O-PEG4-CH2COOH |
83 |
h |
2024-12-20 |
76371 |
Fmoc-PEG2-Val-Cit-PAB-OH,CAS号:2055024-59-2 |
74 |
WYQ |
2024-12-20 |
76372 |
BnO-PEG1-CH2CO2tBu |
237 |
h |
2024-12-20 |
76373 |
cas:824426-32-6,Azidoacetic acid NHS ester,叠氮乙酸 NHS 酯, ADC试剂 |
113 |
kx |
2024-12-20 |
76374 |
Boc-NH-(CH2)15-COOH , 135747-73-8 |
110 |
wyh |
2024-12-20 |
76375 |
Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
92 |
WYQ |
2024-12-20 |
76376 |
t-Butyl acetate-PEG3-CH2COOH |
99 |
h |
2024-12-20 |
76377 |
鼠尾草酸转铁蛋白结合脂质体,Tf-LP-CA,定制服务 |
114 |
axc |
2024-12-20 |
76378 |
Cbz-NH-PEG10-CH2COOH |
126 |
h |
2024-12-20 |
76379 |
cas:2182601-80-3,Azido-PEG8-CH2CO2-PFP |
119 |
wyh |
2024-12-20 |
76380 |
CAS: 2746391-62-6 MAL-di-EG-Val-Cit-PAB-MMAE |
120 |
zyl |
2024-12-20 |
76381 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate,ADC定制 |
98 |
kx |
2024-12-20 |
76382 |
CAS: 2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH |
123 |
WYQ |
2024-12-20 |
76383 |
Cbz-NH-PEG8-CH2COOH |
178 |
h |
2024-12-20 |
76384 |
CAS: 2055024-60-5,NH2-PEG6-Val-Cit-PAB-OH |
94 |
WYQ |
2024-12-20 |
76385 |
苄基-PEG4-乙酸叔丁酯,cas:1443467-88-6,Benzyl-PEG4-CH2CO2tBu |
92 |
wyh |
2024-12-20 |
76386 |
Boc-NH-PEG6-CH2COOH |
115 |
h |
2024-12-20 |
76387 |
NEs介导的紫杉醇脂质体药物递送系统(NE-LP-PTX),定制服务 |
140 |
axc |
2024-12-20 |
76388 |
perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,抗体药物偶联物(ADC) |
94 |
kx |
2024-12-20 |
76389 |
CAS: 2055024-61-6,NH2-PEG4-Val-Cit-PAB-OH |
94 |
WYQ |
2024-12-20 |
76390 |
Azido-PEG7-CH2COOH |
87 |
h |
2024-12-20 |
76391 |
mb-vc-MGBA-ADC连接子 |
107 |
zyl |
2024-12-20 |
76392 |
Azido-PEG2-CH2COOH |
98 |
h |
2024-12-20 |
76393 |
cas:1263044-88-7,2,5-dioxopyrrolidin-1-yl 1-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate |
71 |
kx |
2024-12-20 |
76394 |
Br-PEG6-CH2COOtBu |
86 |
h |
2024-12-20 |
76395 |
白蛋白结合肽修饰的地塞米松脂质体,ABD-Lip/Dex,定制服务 |
96 |
axc |
2024-12-20 |
76396 |
Maleimido-mono-amide-DOTA cas:1006711-90-5 |
89 |
zyl |
2024-12-20 |
76397 |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate,ADC定制 |
100 |
kx |
2024-12-20 |
76398 |
Tos-PEG3-CH2COOtBu |
103 |
h |
2024-12-20 |
76399 |
溶菌酶修饰的百里香精油脂质体,定制服务 |
153 |
axc |
2024-12-20 |
76400 |
HO-PEG7-CH2COOH |
139 |
h |
2024-12-20 |
76401 |
Mc-vc-PABC-SP 141 -ADC连接子 |
119 |
zyl |
2024-12-20 |
76402 |
CAS: 2055024-53-6,Boc-PEG6-Val-Cit-PAB-OH |
140 |
WYQ |
2024-12-20 |
76403 |
cas:1252257-56-9,2,5-dioxopyrrolidin-1-yl 3-oxo-1-(pyridin-2-yldisulfanyl)-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate |
91 |
kx |
2024-12-20 |
76404 |
Amino-PEG12-CH2COOH |
78 |
h |
2024-12-20 |
76405 |
CAS: 2055024-54-7,Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
85 |
WYQ |
2024-12-20 |
76406 |
HO-PEG12-CH2COOH |
90 |
h |
2024-12-20 |
76407 |
cas:663599-07-3,1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
92 |
kx |
2024-12-20 |
76408 |
E-选择素结合肽修饰并加载四嗪的膜融合脂质体,EBP-Tz-FLs,定制服务 |
169 |
axc |
2024-12-20 |
76409 |
Amino-PEG3-CH2COOH |
96 |
h |
2024-12-20 |
76410 |
CAS: 2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH |
162 |
WYQ |
2024-12-20 |